Terns Pharmaceuticals, Inc. - Common Stock (NQ:TERN)

39.19 -0.26 (-0.66%)

Streaming Delayed Price Updated: 3:20 PM EST, Feb 20, 2026 Add to My Watchlist

Price and Volume

Volume	832,029
Open	39.28
Bid (Size)	39.15 (400)
Ask (Size)	39.24 (100)
Prev. Close	39.45
Today's Range	38.77 - 39.99
52wk Range	1.865 - 48.26
Shares Outstanding	61,071,897
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗

Today 0:22 EST

Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s...

Via The Motley Fool

Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗

February 17, 2026

This clinical-stage biotech develops therapies for NASH and obesity, advancing a diverse pipeline of small-molecule drug candidates.

Via The Motley Fool

Performance

YTD	-2.3%	-2.3%
1 Month	+7.1%	+7.1%
3 Month	+50.1%	+50.1%
6 Month	+479.7%	+479.7%
1 Year	+835.3%	+835.3%

More News

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

February 02, 2026

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗

January 14, 2026

Via Stocktwits

Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference

January 07, 2026

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Stay updated with the stocks that are on the move in today's after-hours session. ↗

January 02, 2026

Via Chartmill

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

January 02, 2026

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

December 11, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Announces Pricing of Upsized $650 Million Public Offering

December 09, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Announces Proposed Public Offering

December 09, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗

December 03, 2025

Via The Motley Fool

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗

November 17, 2025

Via Benzinga

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

November 14, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

November 10, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

November 04, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday ↗

November 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 04, 2025

Via Benzinga

Which stocks are moving on Monday? ↗

November 03, 2025

Via Chartmill

Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday ↗

November 03, 2025

Via Benzinga

Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades ↗

November 03, 2025

Via Benzinga

Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session. ↗

November 03, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 03, 2025

Via Benzinga

Gapping stocks in Monday's session ↗

November 03, 2025

Via Chartmill

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

November 03, 2025

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data? ↗

October 22, 2025

Via Benzinga

Frequently Asked Questions

Is Terns Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Terns Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Terns Pharmaceuticals, Inc. - Common Stock trade on?

Terns Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock is TERN on the Nasdaq Stock Market

What is the current price of Terns Pharmaceuticals, Inc. - Common Stock?

The current price of Terns Pharmaceuticals, Inc. - Common Stock is 39.19

When was Terns Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Terns Pharmaceuticals, Inc. - Common Stock was at 02/20/26 03:20 PM ET

What is the market capitalization of Terns Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Terns Pharmaceuticals, Inc. - Common Stock is 2.39B

How many shares of Terns Pharmaceuticals, Inc. - Common Stock are outstanding?

Terns Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.